Tempest Therapeutics (NASDAQ:TPST) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.76) by 17.11 percent. This is a 3250 percent decrease over earnings of $0.02 per share from the same period last year.
China Ousts Official Amid Gaming Regulation Backlash, Wiping Billions Off Major Game Stocks
Amid gaming regulation turmoil, key official Feng Shixin ousted from China's press regulator. NPPA's rules led to major stock declines, erasing nearly $80 billion, including Tencent's market value.
